Celltrion Poised to Roll Out 20 Biosimilars in Japan over Next 10 Years

Celltrion Healthcare Japan President JooSik Choi South Korean biopharma giant Celltrion is rolling up its sleeves for full-fledged inroads into the Japanese market, aiming to introduce as many as 20 biosimilar products in the country by 2030, with five now...read more